Moore Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Moore Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-78,952	Closed	-$1.56M	–	295
2019 Q4	$1.56M	Buy	+78,952	New	+$1.26M	0.05%	198

Moore Capital Management's MNTA Position: Q1 2020 in Review

Moore Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2020, closing a stake of 78,952 shares — an estimated $1.56M sold.

Moore Capital Management first reported a position in MNTA in Q4 2019 and held it in 1 quarter. The position peaked at $1.56M in Q4 2019. 199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

Moore Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Moore Capital Management sold 78,952 Momenta Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.56M.
Moore Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2019 and held it in 1 quarter.
Moore Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.56M in Q4 2019.
199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on Moore Capital Management's 13F filing for Q1 2020, filed 15 May 2020.